www.biovascularinc.com
Open in
urlscan Pro
68.178.247.87
Public Scan
URL:
http://www.biovascularinc.com/
Submission: On December 27 via api from US — Scanned from DE
Submission: On December 27 via api from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Contact Info/Directions Investors Saratin Cardiovascular Risk Reduction Saratin Endovascular Procedures A.V. Grafts Our Strategy Management Board of Directors Home Page > BioVascular's mission is to develop and commercialize novel cardiovascular > therapeutics for significant unmet medical needs. > BioVascular Inc. is a privately held biotechnology company that develops drugs > and devices for the control of intimal hyperplasia associated with vascular > procedures and control of risk factors associated with cardiovascular > morbidity and mortality. > > BioVascular's lead product, saratin, is a polypeptide produced by recombinant > means in yeast. This product was licensed from Merck, KGaA in 2005. > BioVascular began human clinical trials of saratin for hemodialysis graft > access in late 2006 and will begin human trials in the treatment of peripheral > artery grafts in early 2007. > > BioVascular’s second product utilizes a novel mechanism for reduction of a > recently defined cardiovascular risk factor. This product will enter human > studies in mid 2007. Website design: Evenayr Graphics, Portland Oregon, Evenayr@hotmail.com